AIIMS
REGN icon

Analyst IMS Investment Management Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Analyst IMS Investment Management Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.1M Hold
1,425
– – 0.03% 83
2025
Q4 		$1.1M Hold
1,425
– – 0.03% 76
2025
Q3 		$801K Hold
1,425
– – 0.02% 92
2025
Q2 		$748K Hold
1,425
– – 0.03% 99
2025
Q1 		$904K Hold
1,425
– – 0.04% 92
2024
Q4 		$1.01M Hold
1,425
– – 0.04% 82
2024
Q3 		$1.5M Hold
1,425
– – 0.06% 67
2024
Q2 		$1.5M Hold
1,425
– – 0.06% 59
2024
Q1 		$1.37M Hold
1,425
– – 0.06% 56
2023
Q4 		$1.25M Hold
1,425
– – 0.07% 54
2023
Q3 		$1.19M Hold
1,425
– – 0.07% 48
2023
Q2 		$1.01M Hold
1,425
– – 0.07% 53
2023
Q1 		$1.16M Sell
1,425
-62
-4% -$46.8K 0.09% 48
2022
Q4 		$1.07M Sell
1,487
-290
-16% -$214K 0.09% 53
2022
Q3 		$1.23M Sell
1,777
-73
-4% -$45.9K 0.12% 47
2022
Q2 		$1.09M Sell
1,850
-370
-17% -$241K 0.1% 58
2022
Q1 		$1.55M Sell
2,220
-630
-22% -$399K 0.14% 49
2021
Q4 		$1.83M Buy
2,850
+40
+1% +$24.6K 0.17% 53
2021
Q3 		$1.7M Sell
2,810
-75
-3% -$46.6K 0.21% 51
2021
Q2 		$1.61M Buy
2,885
+80
+3% +$40.5K 0.19% 53
2021
Q1 		$1.33M Buy
2,805
+740
+36% +$360K 0.18% 54
2020
Q4 		$998K Buy
+2,065
New +$1.11M 0.17% 59
2018
Q4 		– Sell
-140
Closed -$57 – 151
2018
Q3 		$57 Buy
+140
New +$53.3K 0.01% 129

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Analyst IMS Investment Management Services's REGN Position: Q1 2026 in Review

Analyst IMS Investment Management Services held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2026 at 1,425 shares worth $1.1M. The position accounts for 0.03% of the portfolio, ranked #83.

Analyst IMS Investment Management Services first reported a position in REGN in Q3 2018 and has held it in 23 quarters since. The position peaked at $1.83M in Q4 2021. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Analyst IMS Investment Management Services held 1,425 shares of Regeneron Pharmaceuticals worth $1.1M as of Q1 2026.
  • Analyst IMS Investment Management Services left its Regeneron Pharmaceuticals share count unchanged in Q1 2026.
  • Regeneron Pharmaceuticals made up 0.03% of Analyst IMS Investment Management Services's portfolio in Q1 2026, its #83 holding.
  • Analyst IMS Investment Management Services first reported a position in Regeneron Pharmaceuticals in Q3 2018 and has held it in 23 quarters since.
  • Analyst IMS Investment Management Services's Regeneron Pharmaceuticals position peaked at $1.83M in Q4 2021.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Analyst IMS Investment Management Services's 13F filing for Q1 2026, filed 23 Apr 2026.